Tackling the Kokoda Trail for melanoma
6 April 2018
Fraser Dykes tackled the Kokoda Trail on an eight day trek in memory of his friend Mark “Bod” Boddison.
Fraser’s trek fell in the middle of Melanoma Institute Australia’s major fundraising and awareness campaign Melanoma March which spans across 22 locations around the country, supporting, remembering and fundraising for past and present melanoma patients.
Out of sight, does not mean out of mind for Fraser and Bod. Friends for nearly 40 years, the pair remained very close after Fraser relocated to Australia from Scotland 19 years ago. “We kept in regular contact despite being on the other side of the world. He visited me in Oz on a number of occasions and I took my family to Scotland and we spent our 40th Birthday’s together”.
Bod was diagnosed with melanoma 11 years ago but was given the all clear. Six years later, due to the viciousness of melanoma, Bod had tumours in his brain, abdomen and other parts of his body. But Bod did not lose his sense of humour or positive attitude. Fraser flew to Scotland to spend some time with his lifelong friend. “Those two weeks were priceless for us”, Fraser said.
Devastatingly, Bod lost his battle on March 11th last year. Fraser took on Kokoda just over one year since Bod passed away. Fraser is hoping to fundraise and raise awareness about melanoma. Even though Scotland doesn’t cop the brunt of extreme UV rays like Australia, melanoma doesn’t discriminate.
Bod left behind his wife Ailsa and daughter Zoe who I keep in regular contact with and they are coping as well as can be expected. I also speak regularly to Bod's parents whom I have known since I was a little schoolboy & I find it very difficult speaking to them as I can hear just how terribly sad they are without Mark.
With three young children who spend a lot of time playing outside, Fraser is patently aware of the dangers of too much sun. “I was shocked to read the statistics regarding young Aussies and melanoma so that fortified my decision to raise funds”, Fraser said.
Fraser braved harsh terrain and difficult trekking conditions including extreme humidity and wet conditions. Fraser took on an incredible challenge for Melanoma Institute Australia and you can help him take it one step further by donating to his cause here.
Australasian Melanoma Conference AMC2021
The 2021 Australasian Melanoma Conference (AMC2021) will held in Sydney, Australia.
Predicting disease spread in thin melanoma
A new MIA online risk calculator for clinicians can determine the likelihood of thin melanoma spreading.
Exploring our own clinical questions through MIA's new trials initiative
MIA has recently established a new division of our Clinical Trials Program which co-ordinates and manages investigator-led multi-centre trials.
Young researchers awarded Fellowships to pursue innovative treatments for melanoma
Two young researchers from MIA and The University of Sydney awarded Cancer Institute NSW fellowships.
Young researchers receive boost to develop innovative treatment for melanoma
Two young researchers from MIA and The University of Sydney awarded Cancer Institute NSW fellowships.
Launch of Melanoma March 2021
Aussies urged to leave their footprint on melanoma as efforts step up to save lives from the disease.
WA Melanoma Community Forum
An evening for WA melanoma patients, carers and the wider melanoma community, where speakers will provide updates on melanoma research, treatment and support.
Olivia Vivian announced as MIA ambassador
Olivia is using her Ninja star power to shine a spotlight on melanoma prevention - in memory of her dad.
Melanoma breakthrough - neoadjuvant treatment saving lives.
Drug treatment before surgery, known as neoadjuvant therapy, is being hailed as one of the biggest breakthroughs in melanoma treatment since the advent of immunotherapy.
Melanoma breakthrough - neoadjuvant therapy saving lives.
Drug treatment before surgery, known as neoadjuvant therapy, is being hailed as one of the biggest breakthroughs in melanoma treatment since the advent of immunotherapy.
Are cancer patients on immunotherapy at a greater risk of severe COVID-19 infection?
New research, led by MIA, has revealed that cancer patients treated with immunotherapy are not at a higher risk of developing severe COVID-19 infection compared to other cancer patients.
Are cancer patients on immunotherapy at a greater risk of severe COVID-19 infection?
New research, led by MIA, has revealed that cancer patients treated with immunotherapy are not at a higher risk of developing severe COVID-19 infection compared to other cancer patients.
A message to all Australians from melanoma patient Stuart Taylor
Stuart has advanced melanoma which is not responding to treatment. He has shared his story on ABC's 7:30 in the hope that others can escape the same fate.
Olivia Vivian nominates MIA as Charity Partner on Channel 9's Celebrity Apprentice.
A Ninja Warrior legend and Olympic gymnast, Olivia knows first hand the devastating impact of melanoma.
It's 'Game On Mole' this summer!
All Australians are urged to join the fight against melanoma this summer.
Prof Richard Scolyer named Outstanding Cancer Researcher of the Year
The ground-breaking work of MIA's Co-Medical Director Prof Richard Scolyer has been recognised with NSW’s highest accolade for cancer research.
Dr James Wilmott wins 2020 Wildfire Highly Cited Publication Award
A landmark study led by MIA's Dr Willmott is making a difference to melanoma treatment around the globe.
MIA researchers feature on prestigious Highly Cited Researchers 2020 List
The highly anticipated annual list is the “who’s who” of the scientific elite from across the globe.
Game On Mole is back this summer!
The uniquely Aussie awareness campaign ‘Game On Mole’ is back for its second year – with a new look but same important message.
RCPA recognition for Professor Richard Scolyer.
Professor Richard Scolyer receives The Royal College of Pathologists of Australasia Distinguished Fellow Award.